These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7109589)

  • 1. The synthesis of 3H labelled steroid-nitrogen mustard derivatives and studies on their action in rat and human prostate.
    Symes EK; Milroy EJ
    J Steroid Biochem; 1982 Jul; 17(1):23-30. PubMed ID: 7109589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.
    Høisaeter PA
    Scand J Urol Nephrol Suppl; 1977; (46):1-72. PubMed ID: 279091
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
    Nilsson I; Liskowski L; Nilsson T
    Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone-induced DNA synthesis in cultured rat ventral prostate: effects of estracyt and its derivatives.
    Buchanan LJ; Riches AC
    Br J Cancer; 1987 Jan; 55(1):47-51. PubMed ID: 3814475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormone-cytostatic complexes on the rat ventral prostate in vivo and in vitro.
    Forsberg JG; Hoisaeter PA
    Vitam Horm; 1975; 33():137-54. PubMed ID: 180672
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of androgen receptor and estramustine binding protein of rat ventral prostatic tissue in organ culture.
    Høisaeter PA; Kadohama N; Corrales JJ; Karr JP; Murphy GP; Sandberg AA
    J Steroid Biochem; 1981 Mar; 14(3):251-60. PubMed ID: 7218791
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol.
    Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1979 Dec; 39(12):5155-64. PubMed ID: 40694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
    Wang LG; Liu XM; Kreis W; Budman DR
    Biochem Pharmacol; 1998 May; 55(9):1427-33. PubMed ID: 10076535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.
    Tew KD; Erickson LC; White G; Wang AL; Schein PS; Hartley-Asp B
    Mol Pharmacol; 1983 Sep; 24(2):324-8. PubMed ID: 6888373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of prostatic secretion protein on uptake of androgen-receptor complex in prostatic cell nuclei.
    Pousette A; Björk P; Carlström K; Forsgren B; Högberg B; Gustafsson JA
    Prostate; 1981; 2(1):23-33. PubMed ID: 6974353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiographic studies of 3H-estramustine in the rat ventral prostate.
    Appelgren LE; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Acta Pharmacol Toxicol (Copenh); 1978 Nov; 43(5):368-74. PubMed ID: 726901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthesis and testing of E-17 alpha-(2-iodovinyl)-5 alpha-dihydrotestosterone and Z-17 alpha-(2-iodovinyl)-5 alpha-dihydrotestosterone as gamma-emitting ligands for the androgen receptor.
    Hoyte RM; MacLusky NJ; Hochberg RB
    J Steroid Biochem; 1990 Jun; 36(1-2):125-32. PubMed ID: 2362441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145).
    Hartley-Asp B; Gunnarsson PO
    J Urol; 1982 Apr; 127(4):818-22. PubMed ID: 7069864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and retention of androgens by the rat ventral prostate and consideration of their use as site directing agents.
    Symes EK
    Biochem Pharmacol; 1982 Oct; 31(20):3231-6. PubMed ID: 6293509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts.
    Hoisaeter PA
    Invest Urol; 1976 Sep; 14(2):85-92. PubMed ID: 972011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the cytosol androgen receptor of the human prostate.
    Wilbert DM; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
    Michel G; Baulieu EE
    Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.